- Blood Glucose Test
- Kidney Function Test
- Bone Profile Test
- Electrolyte Test
- Liver Function Test
- Lipid Profile Test
- Others
Routine Health Screening Market size was valued at USD 55.8 billion in 2023 and is projected to reach USD 87.6 billion by 2030 at a CAGR of 6.6% from 2024 to 2030. Health screening is vital for detecting diseases at an early stage. These tests are commonly used in preventive medicine to assess whether individuals show early signs of risk factors for conditions such as cancer, diabetes, high cholesterol, high blood pressure, and osteoporosis. These screenings are typically recommended based on age, gender, family history, and lifestyle factors to identify potential health risks before symptoms appear. Early identification of health issues allows for timely intervention, potentially reducing the severity of conditions and improving outcomes. Market expansion is driven by higher rates of chronic illnesses, increased funding from governments for population-wide medical screening programs, and the uptake of telemedicine and home-based services.
The introduction of telemedicine in healthcare has boosted the home-based testing market, while digital connectivity in the healthcare system has strengthened the health check-up market during the COVID-19 pandemic. The increasing prevalence of life-threatening diseases, including asymptomatic stages of non-communicable diseases like diabetes, hypertension, cancer, and cardiovascular diseases, is a key industry driver. For instance, over 30% of the U.S. population has prehypertension, increasing the risk of developing high blood pressure. Regular health check-ups help manage conditions effectively, yet only 1 in 4 U.S. adults have their hypertension controlled. However, Key restraints of the routine health screening market include high costs limiting access, the potential for overdiagnosis and false positives causing unnecessary procedures, and challenges in patient compliance and awareness regarding preventive healthcare benefits.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
The increasing prevalence of chronic diseases such as diabetes, high blood pressure, cancer, high cholesterol, and osteoporosis drives the market for health screening. As per the American Diabetes Association, 366 million individuals in the U.S. are likely to contract diabetes by 2030. As per the statistics listed in the International Diabetes Federation (IDF), nearly 643 million people are anticipated to be suffering from diabetes by the end of 2030. Nearly 90% of these people are expected to be living with type 2 diabetes. Additionally, the growing number of elderly individuals, driven by longer life expectancy and greater awareness of early disease detection and treatment, contributes significantly to market growth. Urbanization, rising disposable incomes, increased healthcare infrastructure spending, and evolving lifestyles are additional factors boosting the health screening market. According to WHO, between 2015 and 2050, the proportion of the world's population over 60 years will nearly double from 12% to 22%.
The routine health screening market was valued at USD 55.8 billion in 2023 and is projected to reach USD 87.6 billion by 2030 at a CAGR of 6.6% from 2024 to 2030.
The key players in the routine health screening market are Quest Diagnostics Incorporated, GRAIL, Eurofins Scientific, Exact Sciences Corporation, SYNLAB International GmbH, UNILABS, LabPLUS, BioReference Laboratories, Sonic Healthcare Limited, ACM Global Laboratories, Cerba Healthcare, Quidel Corporation, Innova Medical Group, Amedes Holding GmbH, RadNet, Inc., Natera, Inc., and Trinity Biotech.
The Increasing prevalence of chronic diseases & rise in the geriatric population are the growth drivers of the routine screening market.
High costs and uncertain reimbursement scenarios, shortage of trained healthcare professionals, and low awareness in developing countries are the key factors hampering the growth of the global medical health screening services market.
1.Executive Summary |
2.Global Routine Health Screening Market Introduction |
2.1.Global Routine Health Screening Market - Taxonomy |
2.2.Global Routine Health Screening Market - Definitions |
2.2.1.Test Type |
2.2.2.Sample Type |
2.2.3.Sample Collection |
2.2.4.Region |
3.Global Routine Health Screening Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Routine Health Screening Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Routine Health Screening Market By Test Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. Blood Glucose Test |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Kidney Function Test |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Bone Profile Test |
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Electrolyte Test |
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
5.5. Liver Function Test |
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.5.3. Market Opportunity Analysis |
5.6. Lipid Profile Test |
5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.6.3. Market Opportunity Analysis |
5.7. Others |
5.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.7.3. Market Opportunity Analysis |
6.Global Routine Health Screening Market By Sample Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. Blood |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Urine |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Serum |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Saliva |
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Others |
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
7.Global Routine Health Screening Market By Sample Collection, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. Hospitals |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Homes |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Diagnostic Laboratories |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Offices |
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Others |
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
8.Global Routine Health Screening Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9.North America Routine Health Screening Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. Test Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Blood Glucose Test |
9.1.2.Kidney Function Test |
9.1.3.Bone Profile Test |
9.1.4.Electrolyte Test |
9.1.5.Liver Function Test |
9.1.6.Lipid Profile Test |
9.1.7.Others |
9.2. Sample Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Blood |
9.2.2.Urine |
9.2.3.Serum |
9.2.4.Saliva |
9.2.5.Others |
9.3. Sample Collection Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Hospitals |
9.3.2.Homes |
9.3.3.Diagnostic Laboratories |
9.3.4.Offices |
9.3.5.Others |
9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10.Europe Routine Health Screening Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Blood Glucose Test |
10.1.2.Kidney Function Test |
10.1.3.Bone Profile Test |
10.1.4.Electrolyte Test |
10.1.5.Liver Function Test |
10.1.6.Lipid Profile Test |
10.1.7.Others |
10.2. Sample Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Blood |
10.2.2.Urine |
10.2.3.Serum |
10.2.4.Saliva |
10.2.5.Others |
10.3. Sample Collection Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Hospitals |
10.3.2.Homes |
10.3.3.Diagnostic Laboratories |
10.3.4.Offices |
10.3.5.Others |
10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
11.Asia Pacific (APAC) Routine Health Screening Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Blood Glucose Test |
11.1.2.Kidney Function Test |
11.1.3.Bone Profile Test |
11.1.4.Electrolyte Test |
11.1.5.Liver Function Test |
11.1.6.Lipid Profile Test |
11.1.7.Others |
11.2. Sample Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Blood |
11.2.2.Urine |
11.2.3.Serum |
11.2.4.Saliva |
11.2.5.Others |
11.3. Sample Collection Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Hospitals |
11.3.2.Homes |
11.3.3.Diagnostic Laboratories |
11.3.4.Offices |
11.3.5.Others |
11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12.Middle East and Africa (MEA) Routine Health Screening Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Blood Glucose Test |
12.1.2.Kidney Function Test |
12.1.3.Bone Profile Test |
12.1.4.Electrolyte Test |
12.1.5.Liver Function Test |
12.1.6.Lipid Profile Test |
12.1.7.Others |
12.2. Sample Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Blood |
12.2.2.Urine |
12.2.3.Serum |
12.2.4.Saliva |
12.2.5.Others |
12.3. Sample Collection Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Hospitals |
12.3.2.Homes |
12.3.3.Diagnostic Laboratories |
12.3.4.Offices |
12.3.5.Others |
12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13.Latin America Routine Health Screening Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
13.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Blood Glucose Test |
13.1.2.Kidney Function Test |
13.1.3.Bone Profile Test |
13.1.4.Electrolyte Test |
13.1.5.Liver Function Test |
13.1.6.Lipid Profile Test |
13.1.7.Others |
13.2. Sample Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Blood |
13.2.2.Urine |
13.2.3.Serum |
13.2.4.Saliva |
13.2.5.Others |
13.3. Sample Collection Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Hospitals |
13.3.2.Homes |
13.3.3.Diagnostic Laboratories |
13.3.4.Offices |
13.3.5.Others |
13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1.Quest Diagnostics Incorporated |
14.2.2.GRAIL |
14.2.3.Eurofins Scientific |
14.2.4.Exact Sciences Corporation |
14.2.5.SYNLAB International GmbH |
14.2.6.UNILABS |
14.2.7.LabPLUS |
14.2.8.BioReference Laboratories |
14.2.9.Sonic Healthcare Limited |
14.2.10.ACM Global Laboratories |
14.2.11.Cerba Healthcare |
14.2.12.Quidel Corporation |
14.2.13.Innova Medical Group |
14.2.14.Amedes Holding GmbH |
14.2.15.RadNet, Inc. |
14.2.16.Natera, Inc. |
14.2.17.Trinity Biotech |
15. Research Methodology |
16. Appendix and Abbreviations |